ABSTRACT
Genome-wide association studies (GWASs) have illustrated that pleiotropy is the norm rather than the exception in the genetic architecture of complex traits. Previous methods have been proposed to investigate cross-trait associations; however, these typically suffer from substantially inflated false positive rates, are limited to associations between only two traits, or examine only a subset of genome-wide variants. Here, we introduce SumRank, a novel method for discovering cross-trait associations based on p-values from GWAS summary statistics. Using numerical and genotype simulations, we demonstrated that SumRank had a near-zero false positive rate, in contrast to contemporary meta-analytical approaches that yielded severely inflated rates. We applied SumRank to GWAS summary data of eight psychiatric disorders and identified 515 independent pleiotropic variants across 175 loci, of which 92 were novel and 71 had previously been associated with only one disorder. Overall, SumRank provides a valid and efficient method for genome-wide discovery of pleiotropic variants that underlie a scalable number of traits.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Netherlands Organization for Scientific Research (NWO/ZonMW grant 016.VICI.170.200 [SL, HT], NWO VENI 916.19.151 [SL, HA]).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We used UK Biobank data, a public dataset which can be obtained through a data access application available at https://www.ukbiobank.ac.uk. We also used summary statistics from GWASs conducted by the PGC, which can be obtained from https://www.med.unc.edu/pgc/download-results/. This information has been included in the Data Availability section.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All summary statistics from the PGC can be obtained from https://www.med.unc.edu/pgc/download-results/. The raw UK Biobank data can be obtained through a data access application available at https://www.ukbiobank.ac.uk.
